Vaxcyte, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
0.00 |
0.00 |
21.43 |
63.22 |
459.48 |
2,138.35 |
| Przychód Δ r/r |
0.00% |
0.00% |
inf% |
195.01% |
626.84% |
365.38% |
| Przychód (min) |
0.00 |
0.00 |
21.43 |
62.30 |
459.48 |
2,138.35 |
| Przychód (max) |
0.00 |
0.00 |
21.43 |
64.13 |
459.48 |
2,138.35 |
| EBITDA (średnia) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| EBIT (średnia) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| EBIT % |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Zysk netto (średni) |
-509.62 |
-571.25 |
-493.30 |
-538.41 |
-379.66 |
530.20 |
| Zysk netto % |
-inf% |
-inf% |
-2302.08% |
-851.69% |
-82.63% |
24.79% |
| EPS (średnia) |
-3.91 |
-4.68 |
-4.33 |
-4.51 |
-3.11 |
4.35 |
| Liczba analityków (Przychody) |
0 |
0 |
6 |
6 |
2 |
5 |
| Liczba analityków (EPS) |
5 |
4 |
5 |
5 |
2 |
1 |
| symbol |
PCVX |
PCVX |
PCVX |
PCVX |
PCVX |
PCVX |